RESOURCES

/

FIND A SPECIALIST

/

CONTACT

NephCure and MedLive Offering Free Webinar on IgA Nephropathy

NephCure is teaming up with MedLive to offer a new, live webinar focused on IgA nephropathy (IgAN). Register to join us on Tuesday, June 20 at 3 p.m. ET for “Knowledge Is Power: The Information You Need to Recognize Your Risk and Early Signs of Kidney Disease and Take Action to Optimize Your Treatment.” MedLive is an online education platform dedicated to providing reliable health information that supports shared decision-making with care teams and improved health outcomes.

Featuring an expert panel comprised of a nephrologist, patients, and patient advocates, this presentation will cover how to get an early diagnosis, what the experts say about IgAN, the ins-and-outs of the available treatment options, and what discussions to have with your doctor. They’ll also explore the role of the kidneys and discuss why early kidney screenings are critical to ensuring medical care begins before any irreversible loss of kidney function occurs.

Dr. Michelle O’Shaughnessy, Consultant Nephrologist at University Hospital Galway in Ireland, will present. At the end of the presentation, the panel will take questions from the audience in a live Q&A.

Experts recommend certain strategies for managing IgAN, such as reducing proteinuria and controlling blood pressure. These strategies aim to save your kidneys and delay the disease progression. There are also newer medications that may help with IgAN and pipeline agents that may help delay the need for dialysis.

“Our goal is to empower patients with the information they need to make informed decisions about their care and preserve the health of their kidneys,” said Kelly Helm, NephCure’s Executive Director of Patient Engagement. “We invite everyone to join us for this free webinar to learn about IgAN and how you can take control of your kidney health!”

Learn more and register for the webinar here.

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.